Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Brinda Kakkar"'
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss 3, Pp 280-286 (2021)
Introduction: Transfusion in cirrhotic patients remains a challenge due to the absence of evidence-based guidelines. Our study aimed to determine the indication of transfusion and the associated transfusion thresholds in cirrhotic patients. Methods:
Externí odkaz:
https://doaj.org/article/cefcb1379e5349678813263f87b05230
Autor:
Brinda Kakkar, Raj Nath Makroo, Soma Agrawal, Mohit Chowdhry, Sweta Nayak, Sanjiv Jasuja, Gaurav Sagar, Sandeep Guleria
Publikováno v:
Asian Journal of Transfusion Science, Vol 15, Iss 1, Pp 62-67 (2021)
Background and Aim: Renal transplantation (RT) is the most successful and ideal renal replacement therapy for end-stage renal disease patients. Renal allograft rejection has always been one of the major barriers in successful RT. Our aim was to repor
Externí odkaz:
https://doaj.org/article/0cf171db1d4641e29fd864c028608f05
Publikováno v:
Global Journal of Transfusion Medicine, Vol 6, Iss 2, Pp 205-210 (2021)
Background and Objectives: Screening for transfusion transmissible infections in donated blood can be done by either rapid diagnostic tests (RDTs) or enzyme-linked immunosorbent assay (ELISA) or any other available sensitive immunoassay such as chemi
Externí odkaz:
https://doaj.org/article/8cf8aef7083f46668b0ace86425483a8
Publikováno v:
Global Journal of Transfusion Medicine, Vol 5, Iss 2, Pp 129-134 (2020)
Transfusion-transmitted infections remain a grave concern for blood transfusion services. Thus, our aim was to determine the seroprevalence of human immunodeficiency virus (HIV) infection among Indian blood donors (BDs) and its trend over the past fe
Externí odkaz:
https://doaj.org/article/529f1aa51d5641cd9772056ad1081d1d
Publikováno v:
Saudi Journal of Kidney Diseases and Transplantation, Vol 29, Iss 3, Pp 698-704 (2018)
ABO incompatibility and preformed antibodies against the human leukocyte antigen (HLA) are two impermissible barriers to a successful renal transplantation, especially in highly sensitized patient population. With the availability of effective desens
Externí odkaz:
https://doaj.org/article/a247ad84c4f44c3e98679fa1dd3def05
Publikováno v:
Asian Journal of Transfusion Science, Vol 12, Iss 2, Pp 160-164 (2018)
Transplant recipients are always at a risk of developing anti-human leukocyte antigen (HLA) antibodies due to prior sensitizing events such as blood transfusions, multiple pregnancies, or transplantation. Unexpected positive outcomes can be seen in c
Externí odkaz:
https://doaj.org/article/0ad26095747a45b8be5f2fa296d1afc0
Publikováno v:
Asian Journal of Transfusion Science, Vol 11, Iss 1, Pp 65-68 (2017)
Patients presenting with hyperleukocytosis secondary to acute leukemia, with total leukocyte count or blast count more than 100,000/μL are often considered for leukapheresis, especially if clinical signs of leukostasis are present. Leukostasis is of
Externí odkaz:
https://doaj.org/article/eefd3d2bcf00434586dcb21f6fabc285
Publikováno v:
Transfusion Medicine.
Autor:
Sweta Nayak, Sanjiv Jasuja, Sandeep Guleria, Gaurav Sagar, Raj Nath Makroo, Brinda Kakkar, Mohit Chowdhry, Soma Agrawal
Publikováno v:
Asian Journal of Transfusion Science, Vol 15, Iss 1, Pp 62-67 (2021)
Asian Journal of Transfusion Science
Asian Journal of Transfusion Science
Background and Aim: Renal transplantation (RT) is the most successful and ideal renal replacement therapy for end-stage renal disease patients. Renal allograft rejection has always been one of the major barriers in successful RT. Our aim was to repor
Publikováno v:
Transfusion and Apheresis Science. 61:103437